37 Extreme Actives Dr. Macrene Skin Results
Macrene Alexiades-Armenakas, M.D., Ph.D., F.A.A.D., the Manhattan based Derm-Scientist, announced today that her brainchild, Dr. Macrene Skin Results 37 Extreme Actives high performance anti-aging cream, is available nationwide as an exclusive at all 41 Neiman Marcus locations. This highly advanced cream technology actively combines and micro-targets the greatest number and variety of proven anti-aging ingredients in a single cream. 37 Extreme Actives, winner of the AOL Luxist Reader’s Choice Award for Best Skin Cream Line 2010, is the culmination of the highest level of scientific research and clinical testing, shown to deliver cosmetic anti-aging results comprehensively targeting all categories of skin aging, including but not limited to helping reduce the appearance of wrinkles, redness, and brown spots.
“Dr. Macrene’s 37 Extreme Actives contains key ingredients that correct and repair many common skin problems,” says Hazel Wyatt, Vice President Divisional Merchandise Manager Beauty and Fragrance, “This is a great product to use alone or with your favorite moisturizer or serum.”
37 Extreme Actives includes proven damage reversal, DNA restore, moisturizing and antioxidant ingredients like, among other things, resveratrol, ferulic acid, organic tea, coffee and mushroom polyphenols, T4 Unirepair, soy and the full complement of amino acids. A top-tier independent testing laboratory assessed 37 Extreme Actives in clinical trials using objective tools designed to quantitatively measure cosmetic changes in the multiple categories of skin aging. The results demonstrated highly significant decreases in the appearance of redness, brown spots and wrinkles. “The changes observed are considered to represent a dramatic improvement from baseline…in the appearance of crows’ feet, fine lines/wrinkles, red skin blotches and brown skin blotches” (Essex Testing Laboratories). No instances of skin irritation were noted in the clinical trials, demonstrating outstanding safety.
“37 Extreme Actives provides a safe and highly effective one-step skincare solution™ for all categories of skin aging. Representing the culmination of research from around the globe and harnessing the very best actives in a rational manner, 37 Actives does the thinking for you,” commented Dr. Macrene. “I am proud and privileged to be partnering with Neiman Marcus to reach people across the country with this product.”
37 Extreme Actives is available in Neiman Marcus, www.NeimanMarcus.com and www.DrMacrene.com. Retail price is $295.
About Dr. Macrene Alexiades-Armenakas
As the Derm-Scientist, Macrene Alexiades-Armenakas,’ M.D., Ph.D., F.A.A.D., esteemed background spanning over 20 years encompasses scientific research and clinical dermatology. The recipient of three Harvard degrees: bachelors of arts (A.B.), medical degree(M.D.) and doctorate(Ph.D.) in genetics, Dr. Macrene has spent years in the laboratory investigating various science fields including plant molecular biology, cell and developmental biology, genetics, photobiology and mammalian stem cell biology. As Director of her own Research Clinic and Private Practice in laser and aesthetic dermatology on Park Avenue in New York City, Dr. Macrene’s varied scientific background allows her to proficiently scour scientific literature and critically evaluate new molecules that seem to surface on a daily basis for their efficacy, as well as apply expert knowledge and judgment to predict potential safety issues far in advance.
About The Neiman Marcus Group
The Neiman Marcus Group, Inc. operations include the Specialty Retail Stores segment and the Direct Marketing segment. The Specialty Retail stores segment consists primarily of Neiman Marcus and Bergdorf Goodman stores. The Direct Marketing segment conducts both online and print catalog operations under the Neiman Marcus, Horchow and Bergdorf Goodman brand names. For more information, visit neimanmarcusgroup.com.
Related Posts:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
Comments
No comments yet.
Leave a comment